Back to Startups

ReproNovo

About ReproNovo

ReproNovo is a healthcare startup focused on innovative reproductive technologies aimed at improving fertility treatments and outcomes for patients. The company leverages advanced scientific research to develop solutions that enhance reproductive health.

Business Information
Target Customers
patients fertility clinics healthcare providers
Industry Categories
Software
Business Model
Revenue Model B2B and B2C
Pricing Strategy Subscription-based for clinics, pay-per-treatment for patients
Sales Channels direct sales, partnerships with clinics, online platform
Funding Timeline
Round Date Amount Investors
Series A May 21, 2025 $65.0M Jeito Capital
Series A May 21, 2025 $57.0M Unknown
Founders

No founder information available.

Investors
J
Jeito Capital

Venture Capital

Recent Mentions
raisingfi
Raising.fi @raisingfi
May 21, 2025

New Raise ๐Ÿ›๏ธ Company: ReproNovo ๐Ÿ”— Website: https://t.co/5VVG3YjFH7 ๐Ÿ“Š Amount: โ‚ฌ57 Million ๐Ÿ”„ Round: Series A ๐Ÿงฎ Valuation: N/A โš™๏ธ Industry: Healthcare

eugen12
Eugรจne Schรถn @eugen12
May 21, 2025

ReproNovo raises USD65 million to advance Phase II clinical trials ๐Ÿš€๐Ÿฉบ๐Ÿ‡จ๐Ÿ‡ญ๐ŸŒ ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and womenโ€™s health, closed a $65 million Series A financing round successfully. The Lausanne-based company https://t.co/H1vXGP5dcI

dealertAI
Dealert.ai @dealertAI
May 23, 2025

๐Ÿ‡ซ๐Ÿ‡ท New Deal: Jeito Capital leads a USD 65 million Series A financing round in ReproNovo, aiming to advance innovative therapies for reproductive medicine a... #Mergers & #Acquisitions #mergersandacquisitions #PrivateEquity #Dealert ๐Ÿ”— Link: https://t.co/qa45WDnbGP